| mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
UNC1215 |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
Curcumin |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.0055 |
0.9 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |